Financhill
Back

Design Therapeutics Stock Predictions

Design Therapeutics Stock Forecast

  • Over the next 52 weeks, Design Therapeutics has on average historically risen by 9.4% based on the past 3 years of stock performance.
  • Design Therapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
  • Is Design Therapeutics Stock Undervalued?
    The current Design Therapeutics [DSGN] share price is $5.33. The Score for DSGN is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • DSGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Design Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Design Therapeutics has on average historically risen by 9.4% based on the past 3 years of stock performance.

Design Therapeutics Stock Rating

Sell
35
Design Therapeutics (DSGN) is a Sell

Is Design Therapeutics overpriced?

  • Design Therapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%

Design Therapeutics Stock Price History

Is DSGN stock going to rise?

  • The current trend is moderately bullish and DSGN is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
designtx.com

52-Week Data

52-Week High:
6.91
52-Week Low:
1.96

Prediction Charts

Market Cap:
301.79M
Price in USD:
5.33
Volume:
135.92K
Beta:
1.84

Technical Analysis

SMA50:
4.92
SMA100:
4.44
SMA200:
3.69
52-Wk Change:
115.79%

Stock Predictions

  • Is Design Therapeutics stock public?
    Yes, Design Therapeutics is a publicly traded company.
  • What is the Design Therapeutics stock quote today?
    The Design Therapeutics stock price is 5.33 USD today.
  • How to buy Design Therapeutics stock online?
    You can buy Design Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Sep-10 5.10 5.64 6.91 4.98
Sep-11 5.65 5.22 5.79 5.05
Sep-12 5.36 5.84 6.01 5.35
Sep-13 5.85 5.54 5.97 5.20
Sep-16 5.57 5.55 5.86 5.44
Sep-17 5.62 5.77 5.96 5.55
Sep-18 5.75 5.64 5.87 5.56
Sep-19 5.79 5.86 5.95 5.71
Sep-20 5.82 5.88 6.13 5.77
Sep-23 5.92 5.35 5.92 5.35
Sep-24 5.38 5.40 5.46 5.21
Sep-25 5.41 5.38 5.50 5.31
Sep-26 5.49 5.42 5.54 5.34
Sep-27 5.49 5.33 5.62 5.30

Design Therapeutics Earnings

Design Therapeutics Earnings Report: Per Share Design Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Design Therapeutics Forecast Revenue Growth

Design Therapeutics Stock Analysis: Historical quarterly revenues per share for Design Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.39 per share, and a decrease next year of $0.26 per share.

* Design Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.